HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Propranolol as a first-line treatment for diffuse infantile hepatic hemangioendothelioma.

AuthorsSerine Avagyan, Michelle Klein, Nanda Kerkar, Amy Demattia, Francine Blei, Samantha Lee, Henrietta Kotlus Rosenberg, Ronen Arnon
JournalJournal of pediatric gastroenterology and nutrition (J Pediatr Gastroenterol Nutr) Vol. 56 Issue 3 Pg. e17-20 (Mar 2013) ISSN: 1536-4801 [Electronic] United States
PMID22331019 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Adrenergic beta-2 Receptor Antagonists
  • Antineoplastic Agents
  • Vasoconstrictor Agents
  • Propranolol
  • Thyroxine
Topics
  • Adrenergic beta-2 Receptor Antagonists (administration & dosage, adverse effects, therapeutic use)
  • Antineoplastic Agents (administration & dosage, adverse effects, therapeutic use)
  • Congenital Hypothyroidism (complications, drug therapy)
  • Drug Monitoring
  • Female
  • Hemangioendothelioma (complications, congenital, drug therapy)
  • Hormone Replacement Therapy
  • Humans
  • Infant, Newborn
  • Liver Neoplasms (complications, congenital, drug therapy)
  • Neoplasms, Multiple Primary (complications, congenital, drug therapy)
  • Propranolol (administration & dosage, therapeutic use)
  • Skin Neoplasms (complications, congenital, drug therapy)
  • Thyroxine (therapeutic use)
  • Vasoconstrictor Agents (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: